Cited by 3,960Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, L.A., Salmon, D.P., Lowe, J., Mirra, S.S., Byrne, E.J., Lennox, G., Quinn, N.P., Edwardson, J.A., Ince, P.G., Bergeron, C., Burns, A., Miller, B.L., Lovestone, S., Collerton, D., Jansen, E.N.H., Ballard, C., de Vos, R.A.I., Wilcock, G.K., Jellinger, K.A., Perry, R.H.·1996·Neurology

DOI 10.1212/wnl.47.5.1113

Open this paper in CoChat — free account

Abstract

Recent neuropathologic autopsy studies found that 15 to 25% of elderly demented patients have Lewy bodies (LB) in their brainstem and cortex, and in hospital series this may constitute the most common pathologic subgroup after pure Alzheimer's disease (AD). The Consortium on Dementia with Lewy bodies met to establish consensus guidelines for the clinical diagnosis of dementia with Lewy bodies (DLB) and to establish a common framework for the assessment and characterization of pathologic lesions at autopsy. The importance of accurate antemortem diagnosis of DLB includes a characteristic and often rapidly progressive clinical syndrome, a need for particular caution with neuroleptic medication, and the possibility that DLB patients may be particularly responsive to cholinesterase inhibitors. We identified progressive disabling mental impairment progressing to dementia as the central feature of DLB. Attentional impairments and disproportionate problem solving and visuospatial difficulties are often early and prominent. Fluctuation in cognitive function, persistent well-formed visual hallucinations, and spontaneous motor features of parkinsonism are core features with diagnostic significance in discriminating DLB from AD and other dementias. Appropriate clinical methods for eliciting these key symptoms are described. Brainstem or cortical LB are the only features considered essential for a pathologic diagnosis of DLB, although Lewy-related neurites, Alzheimer pathology, and spongi…

Integrity signals

Registry

Crossref · 10.1212/wnl.47.5.1113

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop*
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citation
Relationships between Lewy bodies and pale bodies in Parkinson's disease
Dale, G. E., Probst, A., Luthert, P., Martin, J., Anderton, B. H., & Leigh, P. N. (1992) · Acta Neuropathologica · doi:10.1007/bf00310030 · Cited by 114

Show all 2 references

Research works printed but not linked: 43

Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
Roman GC, Tatemich ITK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993;43:240-260.
Kosaka K, Yoshimura M, Ikeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease? Clin Neuropathol 1984;3:185-192.
Perry RH Irving D Blessed G et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95:119-139. · DOI
10.1136/jnnp.52.Suppl.6 · DOI
10.1212/WNL.40.1.1 · DOI · Paper page
10.1212/WNL.41.1.1 · DOI
10.1007/BF00319659 · DOI
10.1016/0022-510X(91)90186-B · DOI
Harrington CR, Wischik CM, Hurt J, et al. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau proteins. Dementia 1994;5:215-228.
Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
Byrne EJ, Lennox G, Godwin Austen RB, et al. (Nottingham Group for the study of Neurodegenerative Disorders). Diagnostic criteria for dementia associated with cortical Lewy bodies. Dementia 1991;2:283-284.
McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
10.1136/bmj.305.6844.6 · DOI
Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuro Report 1994;5:747-749.
Sahgal A, Galloway PH, McKeith IG, et al. A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 1992;3:350-354.
Salmon DP Galasko D. Neuropsychological aspects of Lewy body dementia. In: Perry RH McKeith IG Perry EK Dementia with Lewy bodies. New York: eds. Cambridge University Press 1996:99-113. · DOI
10.1136/jnnp.52.1.7 · DOI
Ballard C Harrison RWS Lowery K McKeith IG. Noncognitive symptoms in Lewy body dementia. In: Perry RH McKeith IG Perry EK eds. Dementia with Lewy bodies. New York: Cambridge University Press 1996:67-84. · DOI
10.1136/jnnp.59.1.1 · DOI
McKeith IG Fairbairn AF Harrison RS. The management of the non-cognitive symptoms of Lewy body dementia. In: Perry RH McKeith IG Perry EK eds. Dementia with Lewy bodies. New York: Cambridge University Press 1996:381-396. · DOI
Galasko D, Hansen LA. Lewy body disease. Curr Opin Neurol Neurosurg 1992;5:889-894.
McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
Forstl H, Burns A, Levy R, et al. The Lewy-Body variant of Alzheimer's disease. Clinical and pathological findings. BJ Psychiatry 1993;162:385-392.
McKeith IG. Lewy body disease. Curr Opin Psychiatry 1995;8:252-257.
Galasko D, Saitoh T, Xia T, et al. The apolipoprotein E allele epsilon 4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1995;44:1950-1951.
Saitoh T, Xia Y, Chen X, et al. The CYP2D6B mutant allele is over-represented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995;37:110-112.
Marder K, Maestre G, Cote L, et al. The apoliprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 1996;44:1330-1331.
Armstrong M, Daly AK, Cholerton S, et al. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018.
10.1097/00005072-199301000-00001 · DOI
10.1212/WNL.45.1.1 · DOI
10.1093/brain/118.1.1 · DOI
Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardisation of the neuropathologic assessment for Alzheimer's disease. Neurology 1991;41:479-486.
Hansen LA, Masliah E, Galasko D, et al. Plaque only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-654.
Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol (Berl) 1991;82:239-259.
10.1007/BF00687395 · DOI
Kosaka K, Iseki E, Odawara T, et al. Cerebral type of Lewy body disease - a case report. Neuropathology 1994;16:72-75.
10.1007/BF00686786 · DOI
Langlais PJ, Thal L, Hansen LA. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993;43:1927-1934.
Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinctions from Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7:69-79.
Perry EK, Marshall EF, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
Piggott M Perry EK Marshall EF et al. Nigrostriatal dopaminergic activities in Lewy body dementia in relation to neuroleptic sensitivity: comparison with Parkinson's disease. Biol Psychiatry 1996 (in press).

Sorted by citations

Items 101–188 of 188

Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
Bergeron, D., Gorno‐Tempini, M. L., Rabinovici, G. D., Santos‐Santos, M. A., Seeley, W., Miller, B. L., Pijnenburg, Y., Keulen, M. A., Groot, C., van Berckel, B. N. M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25333 · Cited by 203
Self-citation
Psychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200
Differential diagnosis of neurodegenerative diseases using structural MRI data
Koikkalainen, J., Rhodius-Meester, H., Tolonen, A., Barkhof, F., Tijms, B., Lemstra, A. W., Tong, T., Guerrero, R., Schuh, A., Ledig, C., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.02.019 · Cited by 193
Cerebral correlates of psychotic symptoms in Alzheimer's disease
Mega, M. S. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.2.167 · Cited by 189
Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals
Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., & Katzman, R. (2002) · Neurology · doi:10.1212/wnl.59.7.1022 · Cited by 189
Self-citation
Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies
Mosimann, U. P., Rowan, E. N., Partington, C. E., Collerton, D., Littlewood, E., O'Brien, J. T., Burn, D. J., & McKeith, I. G. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000192480.89813.80 · Cited by 188
Self-citation
Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation
Kril, J., Patel, S., Harding, A., & Halliday, G. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0477-5 · Cited by 190
Improving actigraphic sleep estimates in insomnia and dementia: how many nights?
VAN SOMEREN, E. J. W. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00592.x · Cited by 181
Nicotinic receptors in human brain: topography and pathology
Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180
Self-citation
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.005 · Cited by 167
Self-citation
Synapse loss in dementias
Clare, R., King, V. G., Wirenfeldt, M., & Vinters, H. V. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22392 · Cited by 163
α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation
Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
Microglial Activation Parallels System Degeneration in Multiple System Atrophy
Ishizawa, K., Komori, T., Sasaki, S., Arai, N., Mizutani, T., & Hirose, T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.43 · Cited by 172
Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism
Kuo, Y.-M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue, L. I., Kalback, W. M., Emmerling, M. R., Beach, T. G., & Roher, A. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64947-4 · Cited by 167
Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains
Brazilian Aging Brain Study Group, Grinberg, L. T., de Lucena Ferretti, R. E., Farfel, J. M., Leite, R., Pasqualucci, C. A., Rosemberg, S., Nitrini, R., Saldiva, P. H. N., & Jacob Filho, W. (2007) · Cell and Tissue Banking · doi:10.1007/s10561-006-9022-z · Cited by 169
Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies
Dickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00065-1 · Cited by 168
Self-citation
Clinical-pathologic study of depressive symptoms and cognitive decline in old age
Wilson, R. S., Capuano, A. W., Boyle, P. A., Hoganson, G. M., Hizel, L. P., Shah, R. C., Nag, S., Schneider, J. A., Arnold, S. E., & Bennett, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000715 · Cited by 165
Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
Thomas, A. J., Attems, J., Colloby, S. J., O'Brien, J. T., McKeith, I., Walker, R., Lee, L., Burn, D., Lett, D. J., & Walker, Z. (2017) · Neurology · doi:10.1212/wnl.0000000000003512 · Cited by 165
Self-citation
The effect of age of onset of PD on risk of dementia
Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Kim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., Fields, J. A., Masliah, D., Iba, M., Lee, H.-J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0276-2 · Cited by 157
Left frontotemporal hypoperfusion is associated with aggression in patients with dementia
Hirono, N., Mega, M. S., Dinov, I. D., Mishkin, F., & Cummings, J. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.861 · Cited by 153
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
Welge, V., Fiege, O., Lewczuk, P., Mollenhauer, B., Esselmann, H., Klafki, H.-W., Wolf, S., Trenkwalder, C., Otto, M., Kornhuber, J., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0177-6 · Cited by 152
The Relative Frequency of "Dementia of Unknown Etiology" Increases With Age and Is Nearly 50% in Nonagenarians
Crystal, H. A., Dickson, D., Davies, P., Masur, D., Grober, E., & Lipton, R. B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.713 · Cited by 152
Self-citation
Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
Teaktong, T., Graham, A., Court, J., Perry, R., Jaros, E., Johnson, M., Hall, R., & Perry, E. (2003) · Glia · doi:10.1002/glia.10132 · Cited by 151
Self-citation
The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment
P. Gelber, R., J. Launer, L., & R. White, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322618 · Cited by 149
Neurodegeneration in Normal Brain Aging and Disease
Thal, D. R., Del Tredici, K., & Braak, H. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.23.pe26 · Cited by 149
Overlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146
Rapidly progressive dementia
Geschwind, M. D., Haman, A., & Miller, B. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.001 · Cited by 143
Self-citation
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Boström, F., Hansson, O., & Nielsen, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053250 · Cited by 141
Progression of Mild Cognitive Impairment to Dementia: Contribution of Cerebrovascular Disease Compared With Medial Temporal Lobe Atrophy
Staekenborg, S. S., Koedam, E. L. G. E., Henneman, W. J. P., Stokman, P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.108.531343 · Cited by 139
Neuropathological and transcriptomic characteristics of the aged brain
Miller, J. A., Guillozet-Bongaarts, A., Gibbons, L. E., Postupna, N., Renz, A., Beller, A. E., Sunkin, S. M., Ng, L., Rose, S. E., Smith, K. A., et al. (2017) · eLife · doi:10.7554/elife.31126 · Cited by 134
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases
Youdim, M. B. H., Fridkin, M., & Zheng, H. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.023 · Cited by 128
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case.
Marquié, M., Verwer, E. E., Meltzer, A. C., Kim, S. J. W., Agüero, C., Gonzalez, J., Makaretz, S. J., Siao Tick Chong, M., Ramanan, P., Amaral, A. C., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0482-0 · Cited by 128
Factors associated with cognitive evaluations in the United States
Kotagal, V., Langa, K. M., Plassman, B. L., Fisher, G. G., Giordani, B. J., Wallace, R. B., Burke, J. R., Steffens, D. C., Kabeto, M., Albin, R. L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001096 · Cited by 119
Dementia assessment and management in primary care settings: a survey of current provider practices in the United States
Bernstein, A., Rogers, K. M., Possin, K. L., Steele, N. Z. R., Ritchie, C. S., Kramer, J. H., Geschwind, M., Higgins, J. J., Wohlgemuth, J., Pesano, R., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4603-2 · Cited by 120
Self-citation
Delirium in the Older Emergency Department Patient: A Quiet Epidemic
Han, J. H., Wilson, A., & Ely, E. W. (2010) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2010.03.005 · Cited by 124
Caring for Individuals with Dementia and Cognitive Impairment, Not Dementia: Findings from the Aging, Demographics, and Memory Study
Fisher, G. G., Franks, M. M., Plassman, B. L., Brown, S. L., Potter, G. G., Llewellyn, D., Rogers, M. A. M., & Langa, K. M. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03304.x · Cited by 123
CSF neurofilament proteins in the differential diagnosis of dementia
de Jong, D., Jansen, R. W. M. M., Pijnenburg, Y. A. L., van Geel, W. J. A., Borm, G. F., Kremer, H. P. H., & Verbeek, M. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107326 · Cited by 120
Is synaptic loss a unique hallmark of Alzheimer’s disease?
Scheff, S. W., Neltner, J. H., & Nelson, P. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.028 · Cited by 118
Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
Mattsson, N., Tabatabaei, S., Johansson, P., Hansson, O., Andreasson, U., Månsson, J.-E., Johansson, J.-O., Olsson, B., Wallin, A., Svensson, J., et al. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8147-9 · Cited by 118
Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases
David, R., Koulibaly, M., Benoit, M., Garcia, R., Caci, H., Darcourt, J., & Robert, P. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.08.007 · Cited by 117
Do family caregivers perceive more difficulty when they look after patients with early onset dementia compared to those with late onset dementia?
Arai, A., Matsumoto, T., Ikeda, M., & Arai, Y. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1935 · Cited by 116
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders · doi:10.1002/mds.22322 · Cited by 109
Nucleic acid oxidation: an early feature of Alzheimer's disease
Bradley‐Whitman, M. A., Timmons, M. D., Beckett, T. L., Murphy, M. P., Lynn, B. C., & Lovell, M. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12444 · Cited by 112
Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques
Driscoll, I., Troncoso, J. C., Rudow, G., Sojkova, J., Pletnikova, O., Zhou, Y., Kraut, M. A., Ferrucci, L., Mathis, C. A., Klunk, W. E., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1025-1 · Cited by 104
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients
Wennström, M., Londos, E., Minthon, L., & Nielsen, H. M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111655 · Cited by 104
Lack of initiative and interest in Alzheimer's disease: a single photon emission computed tomography study
Robert, P. H., Darcourt, G., Koulibaly, M. P., Clairet, S., Benoit, M., Garcia, R., Dechaux, O., & Darcourt, J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01088.x · Cited by 98
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies
Nelson, P. T., Kryscio, R. J., Jicha, G. A., Abner, E. L., Schmitt, F. A., Xu, L. O., Cooper, G., Smith, C. D., & Markesbery, W. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bacf9e · Cited by 99
Neuropathology of mild cognitive impairment
Saito, Y., & Murayama, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00806.x · Cited by 92
Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype
Jellinger, K. A., Paulus, W., Wrocklage, C., & Litvan, I. (2001) · BMC Neurology · doi:10.1186/1471-2377-1-3 · Cited by 86
Self-citation
Neuropathologic assessment of participants in two multi‐center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)
Cairns, N. J., Perrin, R. J., Franklin, E. E., Carter, D., Vincent, B., Xie, M., Bateman, R. J., Benzinger, T., Friedrichsen, K., Brooks, W. S., et al. (2015) · Neuropathology · doi:10.1111/neup.12205 · Cited by 86
Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: a neuropathological study
De Reuck, J., Maurage, C.-A., Deramecourt, V., Pasquier, F., Cordonnier, C., Leys, D., & Bordet, R. (2018) · Folia Neuropathologica · doi:10.5114/fn.2018.76610 · Cited by 84
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Nielsen, H. M., Londos, E., Minthon, L., & Janciauskiene, S. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.011 · Cited by 80
Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study
Panegyres, P. K., Rogers, J. M., McCarthy, M., Campbell, A., & Wu, J. S. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-41 · Cited by 81
Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimers Pathology in MCI and AD
Sabbagh, M. N., Cooper, K., DeLange, J., Stoehr, J. D., Thind, K., Lahti, T., Reisberg, B., Sue, L., Vedders, L., Fleming, S. R., et al. (2010) · Current Alzheimer Research · doi:10.2174/156720510791162340 · Cited by 79
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
Kim, C., Beilina, A., Smith, N., Li, Y., Kim, M., Kumaran, R., Kaganovich, A., Mamais, A., Adame, A., Iba, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0399 · Cited by 79
Prevalence of cortical superficial siderosis in a memory clinic population
Zonneveld, H. I., Goos, J. D. C., Wattjes, M. P., Prins, N. D., Scheltens, P., van der Flier, W. M., Kuijer, J. P. A., Muller, M., & Barkhof, F. (2014) · Neurology · doi:10.1212/wnl.0000000000000150 · Cited by 78
Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies
Hashimoto, M., & Masliah, E. (2003) · Neurochemical Research · doi:10.1023/a:1026073324672 · Cited by 78
Cross Currents in Protein Misfolding Disorders: Interactions and Therapy
Morales, R., Green, K., & Soto, C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789541998 · Cited by 72
Preclinical AD Workgroup staging: Pathological correlates and potential challenges
Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71
Tau-induced pathology in epilepsy and dementia: notions from patients and animal models.
Sánchez, M., García-Cabrero, A., Sánchez-Elexpuru, G., Burgos, D., & Serratosa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041092 · Cited by 68
The need to unify neuropathological assessments of vascular alterations in the ageing brain
Alafuzoff, I., Gelpi, E., Al-Sarraj, S., Arzberger, T., Attems, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Englund, E., et al. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.06.001 · Cited by 65
Self-citation
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010386.pub2 · Cited by 66
Multivariate Analysis of Laminar Patterns of Neurodegeneration in Posterior Cingulate Cortex in Alzheimer's Disease
Vogt, B. A., Vogt, L. J., Vrana, K. E., Gioia, L., Meadows, R. S., Challa, V. R., Hof, P. R., & Van Hoesen, G. W. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6852 · Cited by 64
Dementia with Lewy bodies: Challenges in the diagnosis and management
Chin, K. S., Teodorczuk, A., & Watson, R. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419835029 · Cited by 63
Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging
Sabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia
Vermeiren, Y., Le Bastard, N., Van Hemelrijck, A., Drinkenburg, W. H., Engelborghs, S., & De Deyn, P. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.06.010 · Cited by 56
Clinicopathological characteristics of freezing of gait in autopsy‐confirmed Parkinson's disease
Virmani, T., Moskowitz, C. B., Vonsattel, J., & Fahn, S. (2015) · Movement Disorders · doi:10.1002/mds.26346 · Cited by 56
Association of small vessel disease with tau pathology
Kapasi, A., Yu, L., Petyuk, V., Arfanakis, K., Bennett, D. A., & Schneider, J. A. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02397-x · Cited by 55
Why is later age at retirement beneficial for cognition? Results from a French population-based study
Grotz, C., Meillon, C., Amieva, H., Stern, Y., Dartigues, J.-F., Adam, S., & Letenneur, L. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0599-4 · Cited by 52
Higher-order spectral analysis of spontaneous speech signals in Alzheimer’s disease
Nasrolahzadeh, M., Mohammadpoory, Z., & Haddadnia, J. (2018) · Cognitive Neurodynamics · doi:10.1007/s11571-018-9499-8 · Cited by 51
Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
Mak, E., Su, L., Williams, G. B., Watson, R., Firbank, M., Blamire, A. M., & O'Brien, J. T. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.017 · Cited by 51
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia
Burton, E. J., Mukaetova-Ladinska, E. B., Perry, R. H., Jaros, E., Barber, R., & O'Brien, J. T. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.015 · Cited by 43
Self-citation
Trends in postmortem neurodegenerative and cerebrovascular neuropathologies over 25 years
Grodstein, F., Leurgans, S. E., Capuano, A. W., Schneider, J. A., & Bennett, D. A. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5416 · Cited by 41
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study
Müller, M., Kuiperij, H. B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160038 · Cited by 41
Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes
Bouwmans, A. E. P., Vlaar, A. M. M., Srulijes, K., Mess, W. H., & Weber, W. E. J. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)90009-3 · Cited by 40
“Idiopathic” Rapid-Eye-Movement (REM) Sleep Behavior Disorder Is Associated With Future Development of Neurodegenerative Diseases
Hickey, M. G., Demaerschalk, B. M., Caselli, R. J., Parish, J. M., & Wingerchuk, D. M. (2007) · The Neurologist · doi:10.1097/01.nrl.0000257848.06462.46 · Cited by 35
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology
Walker, D. G., Lue, L.-F., Tang, T. M., Adler, C. H., Caviness, J. N., Sabbagh, M. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.007 · Cited by 33
Neuropathological analysis of lacunes and microvascular lesions in late-onset depression: Vascular pathology in late-onset depression
Santos, M., Gold, G., Kövari, E., Herrmann, F. R., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01101.x · Cited by 32
Associations of 24-hour rest-activity rhythm fragmentation, cognitive decline, and postmortem locus coeruleus hypopigmentation in Alzheimer's disease
Van Egroo, M., van Someren, E. J. W., Grinberg, L. T., Bennett, D. A., & Jacobs, H. I. L. (2024) · Annals of Neurology · doi:10.1002/ana.26880 · Cited by 28
Treatment of behavioural symptoms and dementia in Parkinson's disease
Hanagasi, H. A., & Emre, M. (2005) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00317.x · Cited by 24
The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer’s Disease and Modifies the Disease’s Risk in APOE- ɛ 4 Carriers
Montesanto, A., Crocco, P., Anfossi, M., Smirne, N., Puccio, G., Colao, R., Maletta, R., Passarino, G., Bruni, A. C., & Rose, G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150993 · Cited by 24
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
Sugawara Kikuchi, Y., & Shimizu, T. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s189050 · Cited by 14
A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with lewy bodies and Alzheimer’s dementia
Suzuki, Y., Suzuki, M., Shigenobu, K., Shinosaki, K., Aoki, Y., Kikuchi, H., Baba, T., Hashimoto, M., Araki, T., Johnsen, K., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0265484 · Cited by 10
Neuropathology of dementia
Kim, E.-J., Vatsavayai, S., & Seeley, W. W. (2016) · The Behavioral Neurology of Dementia · doi:10.1017/9781139924771.008 · Cited by 7
Fluid markers of synapse degeneration in synucleinopathies
Cervantes González, A., & Belbin, O. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02467-8 · Cited by 7
Predictors of Preclinical Alzheimer Disease and Dementia: A Clinicopathologic Study
Galvin, J. E., Powlishta, K. K., Wilkins, K., McKeel, D. W., Xiong, C., Grant, E., Storandt, M., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.758 · Cited by 2

Authors: McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., Lennox, G., Quinn, N. P., Edwardson, J. A., Ince, P. G., Bergeron, C., Burns, A., Miller, B. L., Lovestone, S., Collerton, D., Jansen, E. N. H., Ballard, C., de Vos, R. A. I., Wilcock, G. K., Jellinger, K. A., & Perry, R. H.
Affiliations: Newcastle upon Tyne Hospital (GB)
ORCID: McKeith, I.G.
Galasko, D.
Dickson, D.W.
Salmon, D.P.
Lowe, J.
Quinn, N.P.
Ince, P.G.
Burns, A.
Miller, B.L.
Lovestone, S.
Collerton, D.
Ballard, C.
Jellinger, K.A.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1996-11
Volume: 47
Issue: 5
Pages: 1113-1124
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.47.5.1113
OpenAlex: W2123056519
Cited by: 3,960
References: 2
Citations by year: 2026: 28 · 2025: 38 · 2024: 46 · 2023: 50 · 2022: 51 · 2021: 72 · 2020: 72 · 2019: 105 · 2018: 106 · 2017: 130 · 2016: 129 · 2015: 119 · 2014: 135 · 2013: 148 · 2012: 160
FWCI: 72.06
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: dementia with Lewy bodies, diagnosis, neuropathology, Lewy bodies, cortical Lewy bodies, Alzheimer's disease, parkinsonism, visual hallucinations, cognitive fluctuations, cholinesterase inhibitors, antipsychotic drugs, frozen tissue storage
MeSH terms: Dementia, Humans, Parkinson Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks